ArticlePeerJ2020

The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review.

Avi Gurion Kaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.